Profil
Krassimir Mitchev is currently the Director & Principal Owner at Arden Regulatory Clinical & Medical Consulting Ltd. and the Head-Medical Affairs at Calliditas Therapeutics AB. Previously, he worked as the Head-Medical Affairs at Calliditas Therapeutics AB in 2019 and as the Vice President at Swedish Orphan Biovitrum AB from 2013 to 2018.
He holds a doctorate degree from Medical University Sofia.
Postes actifs de Krassimir Mitchev
| Sociétés | Poste | Début |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | 24/07/2020 |
Arden Regulatory Clinical & Medical Consulting Ltd. | Directeur/Membre du Conseil | 01/07/2018 |
Anciens postes connus de Krassimir Mitchev
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/05/2018 |
| CALLIDITAS THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | - |
Formation de Krassimir Mitchev
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Medical University Sofia
Medical University Sofia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arden Regulatory Clinical & Medical Consulting Ltd. |
















